RX94

Josh Williams to the BucsGood luck, Josh

Before the escalator. Back when I watched Fox and Friends in the morning before work, Trump would call in to the show every Monday morning.

He always commented on any trade deals or agreements the US had made. He would explain how it was a bad deal or we were losing money.

So when he came down the escalator a year or so later, I knew I’d support him.

This is #fakenews.

My priest spoke about abortion, defending life, gender ideology in schools. He said Christians need to speak up. We will be ridiculed & called garbage.

Said to vote for the politician who is closest to what we believe. Pray for the country & love your neighbor.

Chris Carr is from Louisiana. Turn NV red!!

CoExIsT

Gavin Guidry is the player that hit him Connor Benge

quote:

---

Name Semaglutide ALERT: US Boxed Warning ?Risk of thyroid C-cell tumors


Special Alerts ?Glucagon-Like Peptide-1 Receptor Agonists Safety UpdateJanuary 2024 The FDA has been evaluating reports of suicidal thoughts or actions in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs). A preliminary evaluation has not found evidence that the use of these medicines causes suicidal thoughts or actions, but the FDA is continuing to investigate this issue. Patients should not stop taking GLP-1 RAs without consulting their health care provider. Health care providers should monitor for and advise patients using GLP-1 RAs to report new or worsening depression, suicidal thoughts, or any unusual changes in mood or behavior. Further information may be found at

---

Boxed warning for thyroid cancer & new alert for suicidal thoughts. Already been seeing the lawyer commercials for these meds.

quote:

---

8 days until we get to find out what the S1 call back that will make our eyes roll is.

---

IMDB has Finale on Feb 25.
2 more weeks to finally end this mess.

Black box warning on Singulair fyi:

Montelukast

ALERT: US Boxed Warning
?Serious neuropsychiatric events:
Serious neuropsychiatric (NP) events have been reported with the use of montelukast. The types of events reported were highly variable, and included, but were not limited to, agitation, aggression, depression, sleep disturbances, suicidal thoughts and behavior (including suicide). The mechanisms underlying NP events associated with montelukast use are currently not well understood.

Because of the risk of NP events, the benefits of montelukast may not outweigh the risks in some patients, particularly when the symptoms of disease may be mild and adequately treated with alternative therapies. Reserve use of montelukast for patients with allergic rhinitis who have an inadequate response or intolerance to alternative therapies. In patients with asthma or exercise-induced bronchoconstriction, consider the benefits and risks before prescribing montelukast.

Discuss the benefits and risks of montelukast with patients and caregivers when prescribing montelukast. Advise patients and/or caregivers to be alert for changes in behavior or new NP symptoms when taking montelukast. If changes in behavior are observed, or if new NP symptoms or suicidal thoughts and/or behavior occur, advise patients to discontinue montelukast and contact a health care provider immediately